Literature DB >> 28067666

Versatile humanized niche model enables study of normal and malignant human hematopoiesis.

Ander Abarrategi, Katie Foster, Ashley Hamilton, Syed A Mian, Diana Passaro, John Gribben, Ghulam Mufti, Dominique Bonnet.   

Abstract

The BM niche comprises a tightly controlled microenvironment formed by specific tissue and cells that regulates the behavior of hematopoietic stem cells (HSCs). Here, we have provided a 3D model that is tunable in different BM niche components and useful, both in vitro and in vivo, for studying the maintenance of normal and malignant hematopoiesis. Using scaffolds, we tested the capacity of different stromal cell types to support human HSCs. Scaffolds coated with human mesenchymal stromal cells (hMSCs) proved to be superior in terms of HSC engraftment and long-term maintenance when implanted in vivo. Moreover, we found that hMSC-coated scaffolds can be modulated to form humanized bone tissue, which was also able to support human HSC engraftment. Importantly, hMSC-coated humanized scaffolds were able to support the growth of leukemia patient cells in vivo, including the growth of samples that would not engraft the BM of immunodeficient mice. These results demonstrate that an s.c. implantation approach in a 3D carrier scaffold seeded with stromal cells is an effective in vivo niche model for studying human hematopoiesis. The various niche components of this model can be changed depending on the context to improve the engraftment of nonengrafting acute myeloid leukemia (AML) samples.

Entities:  

Mesh:

Year:  2017        PMID: 28067666      PMCID: PMC5272182          DOI: 10.1172/JCI89364

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  Tissue engineered humanized bone supports human hematopoiesis in vivo.

Authors:  Boris M Holzapfel; Dietmar W Hutmacher; Bianca Nowlan; Valerie Barbier; Laure Thibaudeau; Christina Theodoropoulos; John D Hooper; Daniela Loessner; Judith A Clements; Pamela J Russell; Allison R Pettit; Ingrid G Winkler; Jean-Pierre Levesque
Journal:  Biomaterials       Date:  2015-05-19       Impact factor: 12.479

2.  Implantable microenvironments to attract hematopoietic stem/cancer cells.

Authors:  Jungwoo Lee; Matthew Li; Jack Milwid; Joshua Dunham; Claudio Vinegoni; Rostic Gorbatov; Yoshiko Iwamoto; Fangjing Wang; Keyue Shen; Kimberley Hatfield; Marianne Enger; Sahba Shafiee; Emmet McCormack; Benjamin L Ebert; Ralph Weissleder; Martin L Yarmush; Biju Parekkadan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-12       Impact factor: 11.205

Review 3.  Humanized hemato-lymphoid system mice.

Authors:  Alexandre P A Theocharides; Anthony Rongvaux; Kristin Fritsch; Richard A Flavell; Markus G Manz
Journal:  Haematologica       Date:  2016-01       Impact factor: 9.941

4.  Ectopic human mesenchymal stem cell-coated scaffolds in NOD/SCID mice: an in vivo model of the leukemia niche.

Authors:  Sarah R Vaiselbuh; Morris Edelman; Jeffrey M Lipton; Johnson M Liu
Journal:  Tissue Eng Part C Methods       Date:  2010-06-29       Impact factor: 3.056

5.  Bone marrow-on-a-chip replicates hematopoietic niche physiology in vitro.

Authors:  Yu-suke Torisawa; Catherine S Spina; Tadanori Mammoto; Akiko Mammoto; James C Weaver; Tracy Tat; James J Collins; Donald E Ingber
Journal:  Nat Methods       Date:  2014-05-04       Impact factor: 28.547

6.  Human extramedullary bone marrow in mice: a novel in vivo model of genetically controlled hematopoietic microenvironment.

Authors:  Ye Chen; Rodrigo Jacamo; Yue-xi Shi; Rui-yu Wang; Venkata Lokesh Battula; Sergej Konoplev; Dirk Strunk; Nicole A Hofmann; Andreas Reinisch; Marina Konopleva; Michael Andreeff
Journal:  Blood       Date:  2012-04-05       Impact factor: 22.113

7.  Reconstructing the human hematopoietic niche in immunodeficient mice: opportunities for studying primary multiple myeloma.

Authors:  Richard W J Groen; Willy A Noort; Reinier A Raymakers; Henk-Jan Prins; Linda Aalders; Frans M Hofhuis; Petra Moerer; Jeroen F van Velzen; Andries C Bloem; Berris van Kessel; Henk Rozemuller; Ellen van Binsbergen; Arjan Buijs; Huipin Yuan; Joost D de Bruijn; Michel de Weers; Paul W H I Parren; Jan Jacob Schuringa; Henk M Lokhorst; Tuna Mutis; Anton C M Martens
Journal:  Blood       Date:  2012-05-31       Impact factor: 22.113

8.  A robust xenotransplantation model for acute myeloid leukemia.

Authors:  P V Sanchez; R L Perry; J E Sarry; A E Perl; K Murphy; C R Swider; A Bagg; J K Choi; J A Biegel; G Danet-Desnoyers; M Carroll
Journal:  Leukemia       Date:  2009-07-23       Impact factor: 11.528

9.  AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML.

Authors:  Daniel J Pearce; David Taussig; Kazem Zibara; Lan-Lan Smith; Christopher M Ridler; Claude Preudhomme; Bryan D Young; Ama Z Rohatiner; T Andrew Lister; Dominique Bonnet
Journal:  Blood       Date:  2005-10-18       Impact factor: 22.113

10.  In vivo ectopic implantation model to assess human mesenchymal progenitor cell potential.

Authors:  Ander Abarrategi; Raquel Perez-Tavarez; Miguel Angel Rodriguez-Milla; Isabel Cubillo; Francisca Mulero; Arantzazu Alfranca; Jose Luis Lopez-Lacomba; Javier García-Castro
Journal:  Stem Cell Rev Rep       Date:  2013-12       Impact factor: 5.739

View more
  35 in total

1.  Acute myeloid leukemia including favorable-risk group samples engraft in NSG mice: just be patient.

Authors:  Dominique Bonnet
Journal:  Haematologica       Date:  2017-05       Impact factor: 9.941

2.  NSG-S mice for acute myeloid leukemia, yes. For myelodysplastic syndrome, no.

Authors:  Emmanuel Griessinger; Michael Andreeff
Journal:  Haematologica       Date:  2018-06       Impact factor: 9.941

Review 3.  Designing natural and synthetic immune tissues.

Authors:  Emily A Gosselin; Haleigh B Eppler; Jonathan S Bromberg; Christopher M Jewell
Journal:  Nat Mater       Date:  2018-05-21       Impact factor: 43.841

4.  Autophagic Mediators in Bone Marrow Niche Homeostasis.

Authors:  Dimitrios Agas; Maria Giovanna Sabbieti
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 5.  Where Hematopoietic Stem Cells Live: The Bone Marrow Niche.

Authors:  Krzysztof Szade; Gunsagar S Gulati; Charles K F Chan; Kevin S Kao; Masanori Miyanishi; Kristopher D Marjon; Rahul Sinha; Benson M George; James Y Chen; Irving L Weissman
Journal:  Antioxid Redox Signal       Date:  2018-01-09       Impact factor: 8.401

6.  Generation and use of a humanized bone-marrow-ossicle niche for hematopoietic xenotransplantation into mice.

Authors:  Andreas Reinisch; David Cruz Hernandez; Katharina Schallmoser; Ravindra Majeti
Journal:  Nat Protoc       Date:  2017-09-21       Impact factor: 13.491

Review 7.  Engineering human hematopoietic environments through ossicle and bioreactor technologies exploitation.

Authors:  Pia Sommerkamp; François E Mercier; Adam C Wilkinson; Dominique Bonnet; Paul E Bourgine
Journal:  Exp Hematol       Date:  2020-12-02       Impact factor: 3.084

8.  Culturing patient-derived malignant hematopoietic stem cells in engineered and fully humanized 3D niches.

Authors:  Andrés García-García; Thibaut Klein; Gordian Born; Morgane Hilpert; Arnaud Scherberich; Claudia Lengerke; Radek C Skoda; Paul E Bourgine; Ivan Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-05       Impact factor: 11.205

9.  Preclinical modeling of myelodysplastic syndromes.

Authors:  K Rouault-Pierre; S A Mian; M Goulard; A Abarrategi; A Di Tulio; A E Smith; A Mohamedali; S Best; A-M Nloga; A G Kulasekararaj; L Ades; C Chomienne; P Fenaux; C Dosquet; G J Mufti; D Bonnet
Journal:  Leukemia       Date:  2017-06-02       Impact factor: 11.528

Review 10.  Modeling the human bone marrow niche in mice: From host bone marrow engraftment to bioengineering approaches.

Authors:  Ander Abarrategi; Syed A Mian; Diana Passaro; Kevin Rouault-Pierre; William Grey; Dominique Bonnet
Journal:  J Exp Med       Date:  2018-02-16       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.